# Simultaneous Component Analysis of Akebia quinata Seeds (Lardizabalaceae) by Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry for Quality and Cytotoxicity Assessment

**Authors:** Chang-Seob Seo, Jaemoo Chun, Kwang Hoon Song

PMC · DOI: 10.3390/plants14050669 · Plants · 2025-02-21

## TL;DR

This paper introduces a new method to analyze the chemical components of Akebia quinata seeds and assess their quality and cytotoxic effects on cancer cells.

## Contribution

A validated UPLC–MS/MS method for simultaneous analysis of eight compounds in Akebia quinata seeds is developed for quality and cytotoxicity assessment.

## Key findings

- The developed UPLC–MS/MS method showed good linearity, recovery, and precision for analyzing eight compounds in Akebia quinata seeds.
- Dipsacoside B exhibited high cytotoxicity across multiple human cancer cell lines.
- The method provides a reliable basis for quality assessment and clinical research of Akebia quinata seed extracts.

## Abstract

Akebia quinata seeds (AQSs) are used as an analgesic, antiphlogistic, and diuretic in traditional herbal medicine. We developed an ultra-performance liquid chromatography with tandem mass spectrometry (UPLC–MS/MS) simultaneous component analysis method to analyze eight compounds (chlorogenic acid, isochlorogenic acid A, isochlorogenic acid C, hederacolchiside F, hederacoside C, dipsacoside B, akebia saponin D, and α-hederin) as markers for the quality assessment of AQSs. The separation of the eight analytes was performed in an Acquity UPLC BEH C18 reversed-phase analytical column. The method was validated with respect to linearity (coefficient of determination ≥ 0.994), recovery (90.32–108.18%; relative standard deviation (RSD) < 10.0%), and precision (RSD < 10%). The analysis of the AQSs confirmed that the eight components were found in concentrations of 0.42–9.07 mg/g. The cytotoxicity of the AQS extract and the eight compounds against human cancer cell lines, including MDA-MB-231 (breast), A549 (lung), HCT 116 (colon), AsPC-1 (pancreas), and A2780 (ovarian), was also assessed, with cisplatin used as a positive control. In addition, dipsacoside B showed high cytotoxicity in all cell lines. This assay will help to enhance efficacy and clinical research as well as provide a validated quality assessment of AQS extract and related traditional herbal medicines.

## Linked entities

- **Chemicals:** chlorogenic acid (PubChem CID 1794427), isochlorogenic acid A (PubChem CID 6474310), isochlorogenic acid C (PubChem CID 460890), hederacolchiside F (PubChem CID 11629562), hederacoside C (PubChem CID 11491905), dipsacoside B (PubChem CID 14284443), akebia saponin D (PubChem CID 14284436), cisplatin (PubChem CID 5460033)
- **Diseases:** breast cancer (MONDO:0004989), lung cancer (MONDO:0005138), colon cancer (MONDO:0002032), pancreatic cancer (MONDO:0005192), ovarian cancer (MONDO:0005140)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** colon (MESH:D003108), pancreas (MESH:D010190), cancer (MESH:D009369), ovarian (MESH:D010049), breast (MESH:D061325), Cytotoxicity (MESH:D064420)
- **Chemicals:** dipsacoside B (MESH:C083461), hederacoside C (MESH:C482302), isochlorogenic acid A (MESH:C100434), cisplatin (MESH:D002945), chlorogenic acid (MESH:D002726), alpha-hederin (MESH:C000588664), AQS (-), akebia saponin D (MESH:C534004)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), A2780 — Homo sapiens (Human), Ovarian endometrioid adenocarcinoma, Cancer cell line (CVCL_0134), AsPC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0152), HCT 116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), lung — Homo sapiens (Human), Finite cell line (CVCL_2492)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11901900/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11901900/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC11901900/full.md

---
Source: https://tomesphere.com/paper/PMC11901900